HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert T Jensen Selected Research

S-sulindac

5/2010Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert T Jensen Research Topics

Disease

63Neoplasms (Cancer)
02/2022 - 01/2002
25Lung Neoplasms (Lung Cancer)
01/2021 - 05/2002
20Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2021 - 01/2003
20Gastrinoma
04/2021 - 01/2002
15Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison)
11/2021 - 02/2002
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 01/2003
11Neoplasm Metastasis (Metastasis)
06/2017 - 07/2002
10Carcinoid Tumor (Carcinoid)
01/2018 - 12/2002
8Multiple Endocrine Neoplasia Type 1
01/2021 - 12/2003
7Pancreatitis
07/2014 - 01/2005
6Primitive Neuroectodermal Tumors (PNET)
01/2018 - 07/2012
4Chronic Pancreatitis
01/2017 - 12/2002
4Breast Neoplasms (Breast Cancer)
02/2016 - 01/2004
4Hyperparathyroidism
02/2013 - 12/2003
3Insulinoma
04/2021 - 02/2006
3Obesity
10/2018 - 03/2013
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018 - 01/2003
3Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
02/2016 - 12/2008
3Hyperplasia
01/2007 - 12/2002
2Central Nervous System Diseases (CNS Diseases)
01/2021 - 02/2011
2Primary Hyperparathyroidism
02/2016 - 08/2013
2Body Weight (Weight, Body)
01/2015 - 05/2010
2Inflammation (Inflammations)
01/2013 - 02/2002
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
12/2007 - 12/2002
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
12/2007 - 12/2002
2Atrophic Gastritis
01/2007 - 07/2002
2Infections
11/2006 - 02/2002
2Peptic Ulcer (Peptic Ulcers)
02/2006 - 01/2006

Drug/Important Bio-Agent (IBA)

15Peptides (Polypeptides)IBA
08/2021 - 06/2002
15GastrinsIBA
10/2019 - 01/2002
15AcidsIBA
10/2019 - 01/2002
14BombesinIBA
01/2021 - 06/2002
13Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 11/2002
12Tyrosine (L-Tyrosine)FDA Link
08/2021 - 05/2002
12Bombesin Receptors (Bombesin Receptor)IBA
01/2021 - 08/2003
10Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
08/2021 - 11/2002
10bombesin receptor subtype 3IBA
01/2019 - 02/2008
9Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2022 - 01/2002
9Messenger RNA (mRNA)IBA
12/2019 - 02/2002
8Proton Pump InhibitorsIBA
11/2021 - 07/2002
8Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
01/2021 - 01/2003
8ErbB Receptors (EGF Receptor)IBA
10/2019 - 07/2010
7G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2021 - 01/2011
7Hormones (Hormone)IBA
04/2021 - 08/2003
7NeurotensinIBA
01/2021 - 05/2002
6Proteins (Proteins, Gene)FDA Link
12/2019 - 07/2002
6LigandsIBA
01/2019 - 09/2006
6Cholecystokinin (Pancreozymin)IBA
02/2017 - 12/2002
6Glucose (Dextrose)FDA LinkGeneric
01/2016 - 02/2008
6Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
09/2007 - 01/2003
5SecretinFDA Link
11/2021 - 08/2003
5Somatostatin Receptors (Somatostatin Receptor)IBA
11/2021 - 03/2003
5Tyrosine Kinase InhibitorsIBA
01/2021 - 06/2012
5Epidermal Growth Factor (EGF)IBA
01/2017 - 07/2002
5CytokinesIBA
07/2014 - 02/2002
4Pharmaceutical PreparationsIBA
04/2021 - 07/2002
4Biological ProductsIBA
01/2021 - 06/2002
4NeuropeptidesIBA
01/2020 - 01/2003
4Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2004
4CalciumIBA
01/2018 - 11/2006
4Phosphatidylinositols (Phosphatidylinositol)IBA
01/2018 - 01/2012
4Chromogranin AIBA
06/2017 - 07/2003
4ChemokinesIBA
02/2017 - 01/2013
4DNA (Deoxyribonucleic Acid)IBA
01/2012 - 08/2002
3EverolimusFDA Link
02/2022 - 06/2018
3Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
01/2021 - 06/2012
3Octreotide (Sandostatin)FDA LinkGeneric
01/2018 - 01/2002
3Cytotoxins (Cytolysins)IBA
01/2018 - 09/2006
3Insulin (Novolin)FDA Link
01/2017 - 01/2015
3Gefitinib (Iressa)FDA Link
01/2016 - 06/2012
3Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
07/2015 - 12/2002
3Tumor Biomarkers (Tumor Markers)IBA
05/2012 - 07/2003
3neuromedin BIBA
07/2010 - 06/2002
3Gastrin-Releasing PeptideIBA
02/2008 - 06/2002
3CamptothecinIBA
09/2007 - 05/2004
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
09/2007 - 05/2004
2Sunitinib (Sutent)FDA Link
02/2022 - 01/2018
2Peptide Receptors (Peptide Receptor)IBA
02/2022 - 09/2016
2Endothelins (Endothelin)IBA
01/2021 - 01/2017
2Amino AcidsFDA Link
12/2019 - 04/2002
2Neurotensin Receptors (Neurotensin Receptor)IBA
12/2019 - 05/2002
2Phosphotransferases (Kinase)IBA
10/2019 - 01/2017
2Type C PhospholipasesIBA
01/2019 - 01/2018
2Growth Factor ReceptorsIBA
01/2018 - 07/2002
2IntegrinsIBA
02/2017 - 08/2011
2Glucagon-Like Peptide 1 (GLP 1)IBA
02/2017 - 01/2014
2Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
07/2015 - 03/2013
2Metalloproteases (Metalloproteinases)IBA
07/2015 - 08/2011
2NF-kappa B (NF-kB)IBA
01/2012 - 08/2011
2Focal Adhesion Protein-Tyrosine KinasesIBA
01/2012 - 05/2002
2trans-sodium crocetinate (crocetin)IBA
08/2011 - 10/2008
2IronIBA
12/2010 - 01/2006
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
12/2010 - 01/2006
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
05/2008 - 12/2004
2BromidesIBA
09/2006 - 05/2004

Therapy/Procedure

17Therapeutics
02/2022 - 08/2003
4Parathyroidectomy
02/2016 - 12/2003
3Drug Therapy (Chemotherapy)
02/2022 - 01/2002
3Operative Surgical Procedures
09/2012 - 08/2003
3Pancreaticoduodenectomy
02/2006 - 08/2003